Show
Sort by
-
- Journal Article
- A1
- open access
A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration : the Be-Raise study
-
- Journal Article
- A1
- open access
Heterogeneity of synovial molecular patterns in patients with arthritis
-
Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registry
-
Ten-year followup of infliximab therapy in rheumatoid arthritis patients with severe, longstanding refractory disease: a cohort study
-
- Journal Article
- A1
- open access
Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial
-
Three-year follow-up of rituximab in rheumatoid arthritis: results from the Belgian MIRA (MabThera in Rheumatoid Arthritis) registry
-
A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration: the Be-Raise study
-
A twelve-week exploratory phase II trial of GLPG0259 versus placebo in patients with active rheumatoid arthritis and inadequate response to methotrexate
-
Feasibility of a molecular diagnosis of arthritis based on the identification of specific transcriptomic profiles in knee synovial biopsies
-
- Journal Article
- A1
- open access
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies